Use of Minocicline in Patients With Stroke


Phase 1 Results N/A

Summary of Purpose

The investigators will evaluate the National Institute of Health Stroke Scale/Score (NIHSS)in patients with stroke, and then give Minocycline 100mg po every 12 hours or placebo for five days, then perform periodic evaluations to determine the status and degree of neurological sequelae developed.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 March 2012.

1 Oct 2011 5 Mar 2012 1 Nov 2011 1 Jan 2013 1 Mar 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment